2010
DOI: 10.1096/fj.09-152298
|View full text |Cite
|
Sign up to set email alerts
|

Ablation of the very‐long‐chain fatty acid elongase ELOVL3 in mice leads to constrained lipid storage and resistance to diet‐induced obesity

Abstract: Although saturated and monounsaturated very-long-chain fatty acids (VLCFAs) have long been associated with undesirable effects on health, including obesity, heart failure, and atherosclerosis, the physiological role of endogenous synthesis is largely unknown. The fatty acid elongase ELOVL3 is involved in the synthesis of C20-C24 saturated and monounsaturated VLCFAs mainly in liver, brown and white adipose tissue, and triglyceride-rich glands such as the sebaceous and meibomian glands. Here we show that ablatio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

7
69
0

Year Published

2012
2012
2018
2018

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 97 publications
(76 citation statements)
references
References 45 publications
7
69
0
Order By: Relevance
“…Moreover, C18:1 and C20:1 VLCFAs could bind PPAR␥ in vitro (Fig. 6), whose data supported that C18:1 VLCFA acts as PPAR␥ ligand (21,23,25,45) with increasing triglyceride and enhancement of the expression of adipogenic genes such as PPAR␥ and lipoprotein lipase (25). Our data presented here support the notion that VLCFAs are powerful molecules and suggest that, by manipulating the synthesis of saturated and monounsaturated C18 -24 VLCFAs, it may be possible to influence adipose tissue expansion.…”
Section: Discussionsupporting
confidence: 60%
“…Moreover, C18:1 and C20:1 VLCFAs could bind PPAR␥ in vitro (Fig. 6), whose data supported that C18:1 VLCFA acts as PPAR␥ ligand (21,23,25,45) with increasing triglyceride and enhancement of the expression of adipogenic genes such as PPAR␥ and lipoprotein lipase (25). Our data presented here support the notion that VLCFAs are powerful molecules and suggest that, by manipulating the synthesis of saturated and monounsaturated C18 -24 VLCFAs, it may be possible to influence adipose tissue expansion.…”
Section: Discussionsupporting
confidence: 60%
“…Fatty acid assay was performed as described in ( 33 ). Following homogenization of liver samples in methanol/5 mM EGTA (2:1, v/v), lipids corresponding to an equivalent of 1 mg of liver were extracted in the presence of glyceryl triheptadecanoate (0.5 g) as an internal standard.…”
Section: Gc Analysismentioning
confidence: 99%
“…3C), which may trigger excess lipid storage in WAT. ELOVL3 knockout females are resistant to DIO, probably due to a lack of very-long-chain fatty acids (VLCFAs) that stimulate expansion of lipid droplets (34). In Rsl1 Ϫ/Ϫ females, upregulated ELOVL3 in liver during HFD may increase synthesis of VLCFAs that could act in liver or be transported (possibly via lipocalins) to act in WAT to sustain lipogenesis and lead to weight gain (Fig.…”
Section: Discussionmentioning
confidence: 99%
“…3C). Furthermore, Elovl3 is likely to play a key role in the phenotype of Rsl1 Ϫ/Ϫ mice given that Elovl3 knockout females are resistant to DIO (34). Major urinary protein 1 (Mup1) was also markedly upregulated in Rsl1 Ϫ/Ϫ female livers for mice on HFD (Fig.…”
Section: Rsl1mentioning
confidence: 95%